Menu
Currency
GWAS Study

Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians.

Luo Y, Suliman S, Asgari S et al.

31434886 PubMed ID
GWAS Study Type
3980 Participants
36 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LY
Luo Y
SS
Suliman S
AS
Asgari S
AT
Amariuta T
BY
Baglaenko Y
MM
Martínez-Bonet M
IK
Ishigaki K
GM
Gutierrez-Arcelus M
CR
Calderon R
LL
Lecca L
LS
León SR
JJ
Jimenez J
YR
Yataco R
CC
Contreras C
GJ
Galea JT
BM
Becerra M
NS
Nejentsev S
NP
Nigrovic PA
MD
Moody DB
MM
Murray MB
RS
Raychaudhuri S
Chapter II

Abstract

Summary of the research findings

Of the 1.8 billion people worldwide infected with Mycobacterium tuberculosis, 5-15% will develop active tuberculosis (TB). Approximately half will progress to active TB within the first 18 months after infection, presumably because they fail to mount an effective initial immune response. Here, in a genome-wide genetic study of early TB progression, we genotype 4002 active TB cases and their household contacts in Peru. We quantify genetic heritability ([Formula: see text]) of early TB progression to be 21.2% (standard error 0.08). This suggests TB progression has a strong genetic basis, and is comparable to traits with well-established genetic bases. We identify a novel association between early TB progression and variants located in a putative enhancer region on chromosome 3q23 (rs73226617, OR = 1.18; P = 3.93 × 10-8). With in silico and in vitro analyses we identify rs73226617 or rs148722713 as the likely functional variant and ATP1B3 as a potential causal target gene with monocyte specific function.

2,160 Peruvian cases, 1,820 Peruvian controls

Chapter III

Study Statistics

Key metrics and study information

3980
Total Participants
GWAS
Study Type
No
Replicated
Peru
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.